GNH USA

Europe — EMA

Moxonidin Stada (Moxonidine)

GNH USA supplies Moxonidin Stada (Moxonidine), an imidazoline receptor agonist for hypertension. Request a quote for worldwide supply to hospitals worldwide.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidin Stada, is an imidazoline receptor agonist presented as a tablet for oral use. It treats hypertension in adult patients.\n\nGNH India supplies Moxonidin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is an antihypertensive agent that acts on central imidazoline I1 receptors to lower blood pressure.\n\nEssential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension.\nResistant hypertension: helps achieve target blood pressure when other agents are insufficient.\nSecondary hypertension: may be used as adjunct therapy for hypertension due to identifiable causes.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Dry mouth\n- Fatigue\n- Dizziness\n- Headache\n- Nausea\n- Constipation\n\nSerious or Rare Side Effects:\n- Severe hypotension\n- Bradycardia\n- Allergic reactions such as rash or angioedema\n- Hepatic dysfunction\n- Cardiac arrhythmias

What precautions apply to Moxonidine?

Before initiating therapy, clinicians should evaluate individual patient risk factors and monitor for potential complications.\n\nMonitor blood pressure: ensure adequate control without excessive fall.\nAssess renal function: adjust use in patients with impaired clearance.\nReview concomitant antihypertensives: avoid additive hypotensive effects.\nCaution in diabetes: monitor glucose as sympathetic modulation may affect glycaemia.\nAvoid abrupt discontinuation: taper to prevent rebound hypertension.\nStore at room temperature: keep in the original pack, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with several drug classes, requiring careful management.\n\nMajor Interactions (Avoid):\n- Combined use with other central antihypertensives (e.g., clonidine) may cause profound hypotension.\n- Concomitant potent CYP2D6 inhibitors can increase plasma levels.\n- Use with other imidazoline agonists may amplify sympatholytic effects.\n\nModerate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive response.\n- Beta‑blockers: additive heart‑rate reduction.\n- ACE inhibitors or ARBs: monitor renal function and potassium.

Frequently asked questions

What is Moxonidin Stada used for?+
Moxonidin Stada contains the active ingredient moxonidine, which is prescribed to lower elevated blood pressure in adults with essential, resistant, or secondary hypertension. By reducing sympathetic nervous system activity, it helps achieve target blood pressure levels and reduces cardiovascular risk.
How does moxonidine work?+
Moxonidine acts as a selective agonist at central imidazoline I1 receptors. Activation of these receptors diminishes sympathetic outflow from the brain, leading to reduced peripheral vascular resistance, lower heart rate, and a consequent decrease in arterial blood pressure.
What is the usual dose of Moxonidin Stada?+
The appropriate dose is determined by the prescribing clinician based on the patient’s blood pressure, response, and tolerability. The prescriber will start with a low dose and may adjust it gradually to achieve optimal blood pressure control while monitoring for side effects.
Is Moxonidin Stada safe in pregnancy or breastfeeding?+
Safety data for moxonidine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Moxonidin Stada from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Moxonidin Stada compare with other antihypertensive classes?+
Moxonidine belongs to the imidazoline receptor agonist class, offering a different mechanism from ACE inhibitors, ARBs, calcium‑channel blockers, or beta‑blockers. It is particularly useful when a centrally acting agent is desired, and it may have a lower incidence of metabolic side effects compared with some other central antihypertensives.
What are the storage and handling requirements for Moxonidin Stada?+
Store the tablets at room temperature, preferably below 25 °C. Keep them in the original blister or container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.
How is Moxonidin Stada administered?+
Moxonidin Stada is taken orally as a tablet, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken in the morning or evening.
What are the most serious risks associated with Moxonidin Stada?+
The most serious adverse events include severe hypotension, marked bradycardia, allergic reactions such as rash or angioedema, hepatic dysfunction, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like fainting, rapid heartbeat, or signs of an allergic reaction.
Who should not use Moxonidin Stada?+
Moxonidin Stada should be avoided in patients with severe hepatic impairment, known hypersensitivity to moxonidine, or in those who are already on multiple central sympatholytic agents that could cause excessive blood‑pressure lowering. Clinicians should also exercise caution in patients with bradyarrhythmias or unstable heart conditions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Stadapharm Gmbh
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU